Tirzepatide (brand name Zepbound or Mounjaro) is one of the newest and most effective medications for weight management. At Gala GLP-1, we help you access compounded GLP-1/GIP (incl. Tirzepatide) safely and affordably through our telehealth program, supervised by licensed clinicians and supported by ongoing care.
What is Tirzepatide?
Tirzepatide is a once-weekly injectable medication that mimics two naturally occurring hormones in your body, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide). These hormones help regulate appetite, digestion, and blood sugar levels.
Originally developed for type 2 diabetes, tirzepatide has shown powerful weight-loss benefits in non-diabetic adults as well, making it one of the most effective options available today.
How Does Tirzepatide Work?
- Slows stomach emptying so you feel full longer
- Reduces appetite and cravings
- Improves insulin sensitivity
- Helps your body use energy more efficiently
The combination of GLP-1 and GIP activity makes tirzepatide even more effective than earlier GLP-1–only medications like semaglutide.
How Effective Is It for Weight Loss?
In clinical trials, tirzepatide helped participants lose an average of 20% of their body weight after 72 weeks — significantly more than semaglutide, which averaged around 15%.
Results vary, but many Gala GLP-1 members see visible progress within the first 4–6 weeks when paired with consistent use and healthy habits.
How Fast Does It Work?
Most patients begin to notice changes in appetite and energy levels within the first few weeks of starting Gala GLP-1’s program. Meaningful weight loss typically occurs over 8–12 weeks as your dose gradually increases.
See if you qualifyWhat Are the Side Effects?
Like all GLP-1 medications, tirzepatide can cause some temporary gastrointestinal side effects, especially during the first few weeks:
- Nausea
- Constipation
- Diarrhea
- Fatigue
- Stomach discomfort
These symptoms usually improve as your body adjusts. Gala’s medical team monitors your progress closely and helps you manage side effects if they appear.
Who Should Consider Tirzepatide?
Tirzepatide may be right for you if you:
- Have a BMI ≥ 27 with weight-related conditions, or ≥ 30 regardless of comorbidities
- Have struggled to lose weight with diet and exercise alone
- Want medical supervision and structured support
It’s not recommended for those with certain medical conditions (like medullary thyroid cancer, multiple endocrine neoplasia type 2, or pancreatitis). Gala GLP-1’s licensed clinicians review your history to determine eligibility.
How Is Tirzepatide Taken?
Tirzepatide is injected once weekly using a prefilled syringe or pen. Gala GLP-1 provides simple instructions and video guidance so you can self-administer confidently at home. Your clinician will start you on a low dose and gradually increase it over time to reduce side effects and maximize results.
How Long Should You Take Tirzepatide?
Tirzepatide works best when used as part of a long-term weight-management plan. If you stop taking it abruptly, your appetite may return to previous levels. At Gala GLP-1, your provider will help you develop a maintenance strategy that fits your goals, whether that means continuing treatment, tapering, or transitioning to lifestyle-based maintenance.
How Much Does It Cost?
Through Gala GLP-1, compounded GLP-1/GIP (incl. Tirzepatide) costs $199 per month(all-included, with medical evaluation and ongoing support).
Start for $199/moHow to Start with Gala GLP-1
- Take the online quiz — see if you qualify in 2 minutes.
- Get your medication shipped to your door — compounded GLP-1/GIP (incl. tirzepatide) delivered discreetly.
- Start your weekly routine — track results through the Gala GLP-1 platform and stay in touch with your provider.
The Bottom Line
Tirzepatide is one of the most powerful and clinically validated weight-loss treatments available. At Gala GLP-1, we offer Compounded GLP-1/GIP (incl. Tirzepatide) accessible, affordable, and supported by medical experts every step of the way — so you can focus on lasting transformation, not confusion or cost.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Gala GLP-1 is an independent service and is not affiliated with Novo Nordisk or Eli Lilly.